title: Chronic hepatitis C--Swedish experts' meeting recommends combination treatment.
authors.affiliation: Department of Infectious Diseases, Sahlgrenska University Hospital/Ostra, Göteborg, Sweden.
authors.forename: R
authors.initials: R
authors.lastname: Wejstål
authors.forename: B
authors.initials: B
authors.lastname: Fischler
authors.forename: H
authors.initials: H
authors.lastname: Glaumann
authors.forename: G
authors.initials: G
authors.lastname: Norkrans
authors.forename: O
authors.initials: O
authors.lastname: Reichard
authors.forename: A
authors.initials: A
authors.lastname: Sönnerbor
authors.forename: I
authors.initials: I
authors.lastname: Uhnoo
authors.forename: O
authors.initials: O
authors.lastname: Weiland
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D002648:Child; D004359:Drug Therapy, Combination; D016174:Hepacivirus / Q000145:classification / Q000235:genetics; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000821:virology; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D012367:RNA, Viral / Q000097:blood; D012254:Ribavirin / Q000627:therapeutic use*; D013548:Sweden; D019562:Viral Load
chemical_list: D000998:Antiviral Agents; D016898:Interferon-alpha; D012367:RNA, Viral; D012254:Ribavirin